App-Quantinova.ai

Correlation Between the Whole Blood Omega-Score and Red Blood Cell Membrane Omega-3 Index in a Patient Population with Cardiovascular Disease Risk Factors Treated With a Unique Omega-3 Formulation

Jason Yantha - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Is Accelerated Atherosclerosis a Microvascular Complication of Diabetes?

Daniel Venegas-Pino - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Atherosclerotic lesions

Streptozotocin

Structural Characterization of 20 kDa Fragments of Apolipoprotein B100

Marie L Tremblay - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Effect of Sitagliptin Therapy on Triglyceride-Rich Lipoprotein Kinetics in Patients With Type 2 Diabetes

Benoit Lamarche - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Sitagliptin

Bifunctional Role of Autophagy in Intracellular ApoB Degradation and Lipid Droplet Mobilization

Mostafa Zamani - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Scavenger Receptor Class B Type I Is Required for Protection by High-Density Lipoprotein Against Doxorubicin-Induced Apoptosis in Both Mouse and Human Cardiomyocytes and Cardiotoxicity in Mice

Bernardo Trigatti - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiotoxicity

Doxorubicin

Lysosomal Acid Lipase Deficiency Impairs Reverse Cholesterol Transport From Macrophages in LAL-Deficient Mice

You-Hai Xu - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Lysosomal acid lipase deficiency

lipase

Central Glucagon-Like Peptide-1 Reduces Intestinal Chylomicron Production via Melanocortin-4-Receptor Signaling

Chris Baker - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Metabolic syndrome

Exenatide

A Proatherosclerotic Environment Impacts the Function and Cellular Metabolism in Cardiac Mitochondria

Celena Scheede-Bergdahl - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronary Artery Disease

N/A

Plasma PCSK9 Levels Are Positively Correlated With LDL-Cholesterol Concentrations in Familial Hypercholesterolemia

Andre J Tremblay - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypercholesterolemia, Familial, 1

N/A

PTP1B, a Link Between Endoplasmic Reticulum Stress and Endothelial Dysfunction

Ruchi Anderson - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

Thapsigargin

Examination of Factors Affecting the Association of PCSK9 With Low-Density Lipoprotein Particles in Human Plasma

Samantha Sarkar - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypercholesterolemia, Familial, 1

N/A

Cardiovascular Regulation in Mice with Overexpression of the Gene of Vesicular Acetylcholine Transporter (VAChT)

Silvia Guatimosim - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Acetylcholine

Over - Versus Under-Treatment of Older Hypertensives in Canada

Penelope Baker - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Peripheral but Not Central Glucagon-Like Peptide-1 Receptor Agonism Regulates Fasting Dyslipidemia by Reducing VLDL Production

Chris Baker - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Exenatide

Lipoprotein(a) Internalization in HepG2 Cells is Regulated by Proprotein Convertase Subtilisin Kexin Type 9 Through the Low-Density Lipoprotein Receptor

Nabil G Seidah - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Coronary Artery Disease

N/A

The Role of Wnt5b and Wnt11 in Aortic Valve Calcification

Bin Yu - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

The Effects of Diet on Occlusive Coronary Artery Atherosclerosis, Thrombosis and Myocardial Infarction in SR-BI/LDL Receptor Double KO Mice

Bernardo L Trigatti - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

cholic acid

Chemerin and Resistin Expression in Carotid Plaque Instability

Samantha Steinmetz-Wood - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Exercise Restores Impaired Resistance Vessel Function in Hypothalamic Hypoestrogenic Premenopausal Women in Association With Increased Resting Cardiac Output and Decreased Systemic Vascular Resistance

Jack M Goodman - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Filters

28841 Abstracts